Seeking Alpha

Amgen (AMGN -0.7%) underperformed a little today after a U.S. appeals court gave a green light...

Amgen (AMGN -0.7%) underperformed a little today after a U.S. appeals court gave a green light to a securities class-action lawsuit accusing the company of failing to disclose safety information for two anemia drugs, and of promoting unauthorized uses of its products.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs